Optimal SMBG (self-monitoring of blood glucose) practice is associated with improvement in glycemic control in different types of patients
Impact of SMBG on A1C levels in patients with diabetes1
Goals for glycemic management include A1C reduction, FPG lowering, and PPG control
According to the ADA guidelines, a patient’s glycemic goals should individualized, with personal targets based on the following factors2:
Postprandial hyperglycemia is an important target for glycemic control4
PPG is an important glycemic target and contributes significantly to overall glycemia in patients with an A1C level below 9.3%.1-5,7
Bayer’s unique portfolio offers testing features to help optimize your patients’ SMBG practice. Training videos are available to help you educate your patients on the benefits and proper use of these features.